Cytokinetics (CYTK)
NASDAQ: CYTK
· Real-Time Price · USD
50.40
2.57 (5.37%)
At close: Sep 26, 2025, 3:59 PM
51.30
1.79%
After-hours: Sep 26, 2025, 07:49 PM EDT
Cytokinetics Revenue Breakdown
| Period Ending | Jun 30, 2025 |
|---|---|
| Collaboration Revenues Revenue | 2.42M |
| Collaboration Revenues Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 65.72M | 57.37M | 62.34M | 56.65M | 50.82M | 45.5M | 44.11M | 40.11M | 39.72M | 49.66M | 53.97M | 48.22M | 42.72M | 33.07M | 33.81M | 26.2M | 21.2M | 15.6M | 13.91M | 12.3M | 14.16M | 12.45M | 10.58M | 9.75M | 9.84M | 9.44M | 7.56M | 7.16M | 8.05M | 9.26M | 10.26M | 9.66M | 8.44M | 8.12M | 6.67M | 7.22M | 7.09M | 6.84M | 5.53M | 5.28M | 4.5M | 4.37M |
| Selling, General, and Administrative Revenue Growth | +14.56% | -7.97% | +10.04% | +11.47% | +11.70% | +3.14% | +9.98% | +0.98% | -20.02% | -7.97% | +11.92% | +12.89% | +29.17% | -2.18% | +29.02% | +23.61% | +35.90% | +12.15% | +13.05% | -13.13% | +13.75% | +17.62% | +8.52% | -0.84% | +4.23% | +24.86% | +5.50% | -10.96% | -13.15% | -9.70% | +6.23% | +14.45% | +3.98% | +21.57% | -7.51% | +1.79% | +3.64% | +23.73% | +4.80% | +17.37% | +2.93% | n/a |
| Research and Development Revenue | 112.55M | 99.84M | 93.63M | 84.61M | 79.6M | 81.57M | 84.98M | 82.53M | 83.19M | 79.42M | 75.02M | 62.73M | 57.13M | 45.94M | 43.5M | 48.44M | 36.44M | 31.56M | 29.22M | 24.2M | 21.79M | 21.74M | 18.33M | 20.23M | 24.02M | 23.55M | 23.28M | 21.39M | 21.58M | 22.14M | 26.25M | 24.95M | 19.81M | 19.29M | 18.78M | 17.86M | 9.72M | 13.53M | 13.25M | 11.56M | 12.64M | 8.96M |
| Research and Development Revenue Growth | +12.73% | +6.63% | +10.66% | +6.30% | -2.42% | -4.01% | +2.96% | -0.80% | +4.75% | +5.87% | +19.58% | +9.82% | +24.36% | +5.60% | -10.19% | +32.91% | +15.47% | +8.01% | +20.74% | +11.07% | +0.24% | +18.57% | -9.37% | -15.77% | +2.00% | +1.15% | +8.82% | -0.88% | -2.50% | -15.68% | +5.23% | +25.94% | +2.70% | +2.73% | +5.10% | +83.74% | -28.16% | +2.15% | +14.64% | -8.54% | +41.09% | n/a |